-
1
-
-
0029868247
-
Multidrug resistance in acute leukemia
-
Sonneveld P: Multidrug resistance in acute leukemia. Baillieres Clin Heamatol 9:185-203, 1996
-
(1996)
Baillieres Clin Heamatol
, vol.9
, pp. 185-203
-
-
Sonneveld, P.1
-
2
-
-
0031049802
-
Multidrug resistance in leukemia
-
McKenna SL, Padua RA: Multidrug resistance in leukemia. Br J Haematol, 96:659-674, 1997
-
(1997)
Br J Haematol
, vol.96
, pp. 659-674
-
-
McKenna, S.L.1
Padua, R.A.2
-
3
-
-
0021059566
-
Multidrug-resistance phenotype in Chinese hamster ovary cells
-
Ling V, Kartner N, Sudo T, et al: Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep 67:869-874, 1983
-
(1983)
Cancer Treat Rep
, vol.67
, pp. 869-874
-
-
Ling, V.1
Kartner, N.2
Sudo, T.3
-
4
-
-
0026683638
-
P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines
-
Nielsen D, Skovsgaard T: P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1139:169-183, 1992
-
(1992)
Biochim Biophys Acta
, vol.1139
, pp. 169-183
-
-
Nielsen, D.1
Skovsgaard, T.2
-
5
-
-
0021031518
-
Drug resistance in Chinese hamster lung and mouse tumor cells
-
Biedler JL, Chang T, Meyers MB, et al: Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67:859-867, 1983
-
(1983)
Cancer Treat Rep
, vol.67
, pp. 859-867
-
-
Biedler, J.L.1
Chang, T.2
Meyers, M.B.3
-
6
-
-
0023589312
-
Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistant phenotype
-
Croop JM, Guild BC, Gros P, et al: Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistant phenotype. Cancer Res 47:5982-5988, 1987
-
(1987)
Cancer Res
, vol.47
, pp. 5982-5988
-
-
Croop, J.M.1
Guild, B.C.2
Gros, P.3
-
7
-
-
0020549246
-
Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers
-
Tsuruo T, Iida H, Nojiri M, et al: Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43:2905-2910, 1983
-
(1983)
Cancer Res
, vol.43
, pp. 2905-2910
-
-
Tsuruo, T.1
Iida, H.2
Nojiri, M.3
-
8
-
-
0030003254
-
Reversal of multidrug resistance in acute myeloid leukemia and other haematological malignancies
-
Sonneveld P: Reversal of multidrug resistance in acute myeloid leukemia and other haematological malignancies. Eur J Cancer 32: 1062-1069, 1996
-
(1996)
Eur J Cancer
, vol.32
, pp. 1062-1069
-
-
Sonneveld, P.1
-
9
-
-
0029963038
-
The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
-
List AF: The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10:36-38, 1996 (suppl 1)
-
(1996)
Leukemia
, vol.10
, Issue.1 SUPPL.
, pp. 36-38
-
-
List, A.F.1
-
10
-
-
0025294910
-
Multidrug resistance and its circumvention
-
Beck WT: Multidrug resistance and its circumvention. Eur J Cancer 26:513-515, 1990
-
(1990)
Eur J Cancer
, vol.26
, pp. 513-515
-
-
Beck, W.T.1
-
11
-
-
0031005627
-
Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (mdr1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy - A Southwest Oncology Group study
-
Leith CP, Kopecky KJ, Godwin J, et al: Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (mdr1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy - A Southwest Oncology Group study. Blood 89:3323-3329, 1997
-
(1997)
Blood
, vol.89
, pp. 3323-3329
-
-
Leith, C.P.1
Kopecky, K.J.2
Godwin, J.3
-
12
-
-
0029869917
-
Cytogenetics and P-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML)
-
Samdani A, Vijapurkar U, Grimm MA, et al: Cytogenetics and P-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML). Leuk Res 20:175-180, 1996
-
(1996)
Leuk Res
, vol.20
, pp. 175-180
-
-
Samdani, A.1
Vijapurkar, U.2
Grimm, M.A.3
-
13
-
-
13344282085
-
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia
-
Del Poeta G, Stasi R, Aronica G, et al: Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 5:1997-2004, 1996
-
(1996)
Blood
, vol.5
, pp. 1997-2004
-
-
Del Poeta, G.1
Stasi, R.2
Aronica, G.3
-
14
-
-
0028923624
-
Clinical studies with modulators of multidrug resistance
-
Fischer GA, Sikic BI: Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am 9:363-382, 1995
-
(1995)
Hematol Oncol Clin North Am
, vol.9
, pp. 363-382
-
-
Fischer, G.A.1
Sikic, B.I.2
-
15
-
-
0026051296
-
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
-
Miller TP, Grogan TM, Dalton WS, et al: P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 9:17-24, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 17-24
-
-
Miller, T.P.1
Grogan, T.M.2
Dalton, W.S.3
-
16
-
-
0029074062
-
Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue SDZ PSC 833
-
Jiang X-R, Kelsey SM, Wu Y-L, et al: Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue SDZ PSC 833. Br J Haematol 90:375-383, 1995
-
(1995)
Br J Haematol
, vol.90
, pp. 375-383
-
-
Jiang, X.-R.1
Kelsey, S.M.2
Wu, Y.-L.3
-
17
-
-
0026014503
-
In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833
-
Boesch D, Gavériaux C, Jachez B: In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 51:4226-4233, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 4226-4233
-
-
Boesch, D.1
Gavériaux, C.2
Jachez, B.3
-
18
-
-
0028941366
-
Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo
-
Watanabe T, Tsuge H, Oh-Hara T, et al: Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34:235-241, 1995
-
(1995)
Acta Oncol
, vol.34
, pp. 235-241
-
-
Watanabe, T.1
Tsuge, H.2
Oh-Hara, T.3
-
19
-
-
10344248680
-
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma: A phase I study
-
Sonneveld P, Marie J-P, Huisman C, et al: Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma: A phase I study. Leukemia 10:1741-1750, 1996
-
(1996)
Leukemia
, vol.10
, pp. 1741-1750
-
-
Sonneveld, P.1
Marie, J.-P.2
Huisman, C.3
-
20
-
-
0030951875
-
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia
-
Kornblau SM, Estey E, Madden T, et al: Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia. J Clin Oncol 15:1796-1802, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 1796-1802
-
-
Kornblau, S.M.1
Estey, E.2
Madden, T.3
-
21
-
-
0003212704
-
Modulation of anthracycline resistance in poor-risk acute myeloid leukemia (AML) with SDZ PSC-833: Results of a phase I/II multicenter study
-
abstr
-
List AF, Karanes C, Dorr R, et al: Modulation of anthracycline resistance in poor-risk acute myeloid leukemia (AML) with SDZ PSC-833: Results of a phase I/II multicenter study. Blood 88:292, 1996 (suppl 1, abstr)
-
(1996)
Blood
, vol.88
, Issue.1 SUPPL.
, pp. 292
-
-
List, A.F.1
Karanes, C.2
Dorr, R.3
-
22
-
-
7844224090
-
A phase I/II study of SDZ PSC 833 (PSC) in combination with daunorubicin (D) and cytarabine in refractory acute myelogenous leukemia (AML)
-
abstr
-
Liliemark J, Björkholm M, Udén A-M, et al: A phase I/II study of SDZ PSC 833 (PSC) in combination with daunorubicin (D) and cytarabine in refractory acute myelogenous leukemia (AML). Blood 88:292, 1996 (suppl 1, abstr)
-
(1996)
Blood
, vol.88
, Issue.1 SUPPL.
, pp. 292
-
-
Liliemark, J.1
Björkholm, M.2
Udén, A.-M.3
-
23
-
-
0028245517
-
Increased intracellular concentrations of doxorubicin in resistant lymphoma cells in vivo by concomitant therapy with verapamil and cyclosporin A
-
Tidefelt U, Juliusson G, Elmhorn-Rosenborg A, et al: Increased intracellular concentrations of doxorubicin in resistant lymphoma cells in vivo by concomitant therapy with verapamil and cyclosporin A. Eur J Haematol 52:276-282, 1994
-
(1994)
Eur J Haematol
, vol.52
, pp. 276-282
-
-
Tidefelt, U.1
Juliusson, G.2
Elmhorn-Rosenborg, A.3
-
24
-
-
0028827712
-
P170 related multidrug resistance: Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo - A report of two cases
-
Damiani D, Michieli M, Michelutti A, et al: P170 related multidrug resistance: Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo - A report of two cases. Leukemia 9:1792-1795, 1995
-
(1995)
Leukemia
, vol.9
, pp. 1792-1795
-
-
Damiani, D.1
Michieli, M.2
Michelutti, A.3
-
25
-
-
0028958138
-
Characterization of an anthracyline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated mdr1 gene expression
-
Jönsson K, Dahlberg N, Tidefelt U, et al: Characterization of an anthracyline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated mdr1 gene expression. Biochem Pharmacol 6:755-762, 1995
-
(1995)
Biochem Pharmacol
, vol.6
, pp. 755-762
-
-
Jönsson, K.1
Dahlberg, N.2
Tidefelt, U.3
-
26
-
-
0030790531
-
Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts
-
Sonneveld P, Wiemer E: Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts. Leukemia 11:1160-1165, 1997
-
(1997)
Leukemia
, vol.11
, pp. 1160-1165
-
-
Sonneveld, P.1
Wiemer, E.2
-
27
-
-
0028314667
-
Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia
-
Tidefelt U, Sundman-Engberg B, Paul C: Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia. Leuk Res 18:293-297, 1994
-
(1994)
Leuk Res
, vol.18
, pp. 293-297
-
-
Tidefelt, U.1
Sundman-Engberg, B.2
Paul, C.3
-
28
-
-
0002261266
-
The pharmacokinetics and bioavailability of a new chemosensitizer, SDZ PSC 833, in patients with advanced cancer
-
abstr
-
Erlichman C, Moore MJ, De Angelis C, et al: The pharmacokinetics and bioavailability of a new chemosensitizer, SDZ PSC 833, in patients with advanced cancer. Anticancer Drugs 5:44, 1994 (suppl 1, abstr)
-
(1994)
Anticancer Drugs
, vol.5
, Issue.1 SUPPL.
, pp. 44
-
-
Erlichman, C.1
Moore, M.J.2
De Angelis, C.3
-
29
-
-
0030895252
-
th AML trial (MRC AML 10) - Adult and Childhood Leukaemia Working Parties of the Medical Research Council
-
th AML trial (MRC AML 10) - Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood 89:2311-2318, 1997
-
(1997)
Blood
, vol.89
, pp. 2311-2318
-
-
Hann, I.M.1
Stevens, R.F.2
Goldstone, A.H.3
-
30
-
-
0030999750
-
Apoptosis and the dilemma of cancer chemotherapy
-
Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845-1853, 1997
-
(1997)
Blood
, vol.89
, pp. 1845-1853
-
-
Hannun, Y.A.1
|